1 Donor’s Written Statement of Understanding Beth H. Shaz, MD Chief Medical Officer New York Blood Center Clinical Associate Professor Emory University.

Slides:



Advertisements
Similar presentations
Research Informed Consent
Advertisements

University Research Ethics Committee Workshop on procedure and data protection issues 30th May 2008.
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
HIPAA – Privacy Rule and Research USCRF Research Educational Series March 19, 2003.
Informed Consent.
THE FOLLOWING SLIDES EXPLAIN THE REQUIRED ELEMENTS THAT MUST BE INCLUDED FOR A HIPAA AUTHORIZATION TO BE VALID HIPAA Authorizations.
Informed consent requirements
LEGAL ISSUES IN AUTHORIZATION FOR ORGAN DONATION IN MISSOURI & KANSAS Laurence R. Tucker November 18, 2011.
Blood Donor Written Statement of Understanding
Research Involving Human Subjects All research involving the participation of human subjects must be submitted for review by the IRB (Institutional Review.
The Consent Process: It’s More Than Just a Form A “10 Minute Training” Brought to you by Cyndi Long, MS, RD, CCRC CU Sports Medicine.
© HRP Associates, Inc. Informed Consent, Parental Permission & Assent Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
INFORMED CONSENT: PROCESS, DOCUMENTATION, ALTERATION AND WAIVERS Suzanne Sparrow.
Institutional Review Boards (IRBs), Informed Consent, and Responsibilities Requirement for IRBs -DHHS: 45 CFR Part 46 -FDA: 21 CFR 56 Requirement for and.
Consenting Withdrawn Subjects for Follow-Up Information Anita Camic Team Leader Research Compliance Administration Tara Bateman Research Compliance Coordinator.
Vicki Hammen, Vice Chair, IRB IRB Brown Bag February 9, 2009.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.
Ethics in Research Stangor Chapter 3.
Treviso, 21 October Karin Magnussen. Donors outside the Blood Bank /Centre Donors in the Blood Bank /Centre Blood products Blood Group serology The Patients.
1 Consent for treatment A summary guide for health practitioners about obtaining consent for treatment Bridie Woolnough Resolution Officer Health Care.
Research Methods for the Social Sciences: Ethics Ryan J. Martin, Ph.D. Thomas N. Cummings Research Fellow March 9, 2010.
How to Avoid Problems in the Informed Consent Process Shannon Ontiveros, MS, CIP, CIM Institutional Review Board.
CBER U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Paula Peyrani, MD Medical/Project Director, HIV Program at the 550 Clinic Assistant Director, Research Design and Development Clinical and Translational.
Northeastern University IRB Division of Research Integrity Application process takes 2-8 weeks.
HRPP Training – Session Two Human Research Protection Program Manager
1 Disclosures © HIPAA Pros 2002 All rights reserved.
Confidentiality, Consents and Disclosure Recent Legal Changes and Current Issues Presented by Pam Beach, Attorney at Law.
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
The IRB Approval Process Michael Bingham, JD Assistant Director, University of Wisconsin-Madison Education IRB
Planned Emergency Research Exception from Informed Consent Requirements September 2007.
May I have your permission please? The consent process: What, Where, When, Who and Why Valerie Smith OHRP IRB Program Manager
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
Family Educational Rights and Privacy Act (FERPA) UNION COLLEGE.
 Purpose  Investigators, Funding  Benefits and Risks  Participation requirements  Duration  Voluntary: Retraction  Information protection and reporting.
The consent in health care.  Defining consent  Age of consent  How to give consent  Factors impacting on the ability to make a decision  The ethical.
Deception in Human Research Learning Objectives Define Deception and Incomplete Disclosure Understand when Deception or Incomplete Disclosure are allowable.
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Unless otherwise noted, the content of this course material is licensed under a Creative Commons 3.0 License.
Dispensary and Administration Site Information Presentation.
What Institutional Researchers Should Know about the IRB Susan Thompson Senior Research Analyst Office of Institutional Research Presented at the Texas.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
Investigational Devices and Humanitarian Use Devices June 2007.
Legally Effective Informed Consent VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and.
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
InformedConsent Q $100 Q $200 Q $300 Q $400 Q $500 Q $100 Q $200 Q $300 Q $400 Q $500 Final JeopardyJeopardy.
Copyright  2000 by Dr. ?????????, Wright State University Dr. ???????? Department of Biomedical, Human Factors, & Industrial Engineering Institutional.
By MUREREREHE Julienne BDT(Hons) KHI..  Informed consent is a legal document, prepared as an agreement for treatment, non-treatment, or for an invasive.
Informed Consent Process Patrick Herbison, MEd, CIP Research Compliance Manager Office of Human Research (OHR)
 The purpose of IRB is to ensure the rights of research subjects are protected  In accordance with the ethical standards of the U.S. Department of Health.
PATIENT & FAMILY RIGHTS AT DOHMS. Fully understand and practice all your rights. You will receive a written copy of these rights from the Reception, Registration.
Research ethics.
Ethics in Research Each research study involves a careful risk/benefit analysis prior to beginning data collection. The question each researcher must ask.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
Informed Consent It’s a Process …not a form. Outline  Historical Background  Respect for Persons  Consent Process  Elements of Informed Consent 
HIPAA and RESEARCH 5 th Thursday May 31, Page 2.
Informed Consent Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
Informed Consent for Transfusion
Upcoming Changes to the Common Rule
Enrolling in Clinical Trials
J. Andrew Bertolatus MD Internal Medicine IRB/HSO 13 Sept 2017
J. Andrew Bertolatus MD Internal Medicine IRB/HSO 12 Apr 2017
HOW TO CONSENT A PATIENT?
J. Andrew Bertolatus MD Internal Medicine IRB/HSO 13 September 2017
The HIPAA Privacy Rule and Research
HOW TO CONSENT A PATIENT?
Office of Research Integrity and Protections
Informed Consent Allison Blodgett, PhD, CIP Director of IRB Operations
Presentation transcript:

1 Donor’s Written Statement of Understanding Beth H. Shaz, MD Chief Medical Officer New York Blood Center Clinical Associate Professor Emory University School of Medicine

2 Transfusion Jun;49(6):

3 Blood collection Is done under the supervision of a licensed physician Has known risks

4 What guidelines exist AMA Code of Ethics AABB Code of Ethics AABB Standards for Blood Banks and Transfusion Services CMS Guidelines for Informed Consent FDA CBER Guidance for Industry: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs FDA Guidance for Institutional Review Boards and Clinical Investigators: A Guide to Informed Consent

5

6 Informed consent process Informed consent is more than simply getting a patient to sign a written consent form. It is a process of communication between a patient and physician that results in the patient's authorization or agreement to undergo a specific medical intervention. In the communications process, you, as the physician providing or performing the treatment and/or procedure (not a delegated representative), should disclose and discuss with your patient: The patient's diagnosis, if known; The nature and purpose of a proposed treatment or procedure; The risks and benefits of a proposed treatment or procedure; Alternatives (regardless of their cost or the extent to which the treatment options are covered by health insurance); The risks and benefits of the alternative treatment or procedure; and The risks and benefits of not receiving or undergoing a treatment or procedure. In turn, your patient should have an opportunity to ask questions to elicit a better understanding of the treatment or procedure, so that he or she can make an informed decision to proceed or to refuse a particular course of medical intervention. topics/informed-consent.page#

7 AABB Standards for Blood Banks and Transfusion Services, 27 th edition Standard 5.2 Information, Consents and Notifications –Elements of the donation procedure shall be explained to the prospective donor in understandable terms. The explanation shall include information about risks of the procedure, tests performed to reduce the risks of transmission of infectious diseases to the allogeneic recipient and requirements to report donor information, including test results, to state or local health departments. The donor shall have an opportunity to ask questions and have them answered and to give or refuse consent for donation. In the case of a minor or a legally incompetent adult, consent shall be addressed in accordance with applicable law.

8 Major elements of informed consent process Disclosure –Sharing material information Comprehension –Ability to understand information Voluntariness –Freedom to make decisions Competence –Ability to make decisions Consent – Decision and authorization Arch Pathol Lab Med 2008;132:

9 Four essential elements of informed consent 1. The reason for, the nature and purpose of, the risks and potential consequences of, the benefits from, and any feasible alternatives to the procedure; 2. The extent, limits, and mechanisms used to maintain confidentiality; 3. Who to contact with questions; and 4. That participation is voluntary and discontinuation is possible at any time without penalty.

10 What are the risks of whole blood donation TRANSFUSION 2008;48:

11

12

13 Goal of study Investigate use, nature and content of informed consent and related materials for whole blood donation Transfusion Jun;49(6):

14 Materials and methods Collection of informed consents and related documents –Blood collection establishments were identified by the AABB and America’s Blood Centers’ Web sites as of 12/1/2007 –Random selection was used to contact establishments –Documents also obtained from the internet or requested Transfusion Jun;49(6):

15 Definitions Informed consent form (ICF): Paper document that was signed by the prospective donor prior to donation Parental consent form (PCF): Paper document the parent or guardian signed to establish proof of permission for the minor to donate General information forms (GIF): Any paper documents that were specifically referred to for reference purposes in the ICF or PCF Transfusion Jun;49(6):

16 Scoring of documents Based on guidance by the FDA and CMS on informed consent for surgical procedures, research subjects and source plasma donors, we determined which elements should be contained All forms were scored independently and differences were reconciled If a single blood establishment used the same forms in multiple states, the forms were only scored once Transfusion Jun;49(6):

17 Guidance and guidelines

18 Transfusion Jun;49(6): The four common essential elements to all consent forms included: 1) the reason for, the nature and purpose of (2 points), the risks and potential consequences of (4 points- 1 point for each of the four most common adverse events, including vasovagal reactions, hematoma and bruising, fatigue, and infection at the site of puncture), the benefits from (2 points), and any feasible alternatives to (as there are no alternatives for blood donation, this element was not scored, 0 points), the procedure; 2) the extent, limits and mechanisms used to maintain confidentiality (4 points total and only 2 points if confidentiality is solely mentioned in the context of infectious disease testing); 3) who to contact with questions (4 points), and 4) that participation is voluntary (2 points) and discontinuation is possible at any time without penalty (2 points). These elements were scored (total 20 points) on ICFs and PCFs and their related GIFs. Common essential elements

19 Transfusion Jun;49(6): An additional set of elements included: 1) description of the procedure: pre/post donation (1 point), donor eligibility/ donor screening (1 point), and estimated time for donation (1 point); 2) infectious disease testing: general statement regarding infection disease testing (1 point), testing for HIV/AIDS (1 point), testing for hepatitis B and C (1 point), reporting positive result to the donor and/or parent (1 point); 3) contact information to report injury (1 point); 4) information regarding donor deferral (1 point); 5) information regarding potential additional medical expenses and/or treatment (1 point); and 6) documentation of the consent by parent/guardian or donor signature on the consent (1 point). These elements were scored (total 11 points) on ICFs and PCFs and their related GIFs. Specific blood donation elements

20 Transfusion Jun;49(6): PCFs should have a number of related and likely important elements such as permission to allow outside medical treatment or emergency transport in the event of a serious reaction. Thus, the authors sought to determine if some of the standard elements of a school field trip consent form that could relate to the blood donation itself or the blood donation process were included in the PCFs under investigation. By identifying and reviewing a number of school field trip consent forms on the internet, a list of the critical components for PCFs was created by the authors. These specialized aspects, which are exclusive of the elements listed for scoring above, include 3 key elements: 1) explanation of the duration of consent (1 point if a consent included a statement such as “this consent is no longer required on your child’s 18th birthday”); 2) parent contact number at the time of donation (1 point), and 3) authorization for medical treatment in case of an emergency (1 point). Unique minor age donor elements

21 Transfusion Jun;49(6): different informed consents with related materials were included 21 ICFs and 37 PCFs 9 hospital-based, 39 community-based and 10 multistate blood collection centers ICFs and PCFs were collected from 48 states Blood establishment forms surveyed represented >90% collected in the US Results

22 Transfusion Jun;49(6): ElementDetailICF (n=21) PCF (n=37) Purpose of donationPurpose of the consent form100% Risks and potential consequences Light-headed/dizziness/ loss of conscience38%51% Bruising/ hematoma33%54% Weakness/fatigue0%5% Infection at site of puncture24%30% Description of any benefits Benefits of donating0%51% Statement describing the extent of confidentiality of records Confidentiality of donor records33%28% Explanation of whom to contact for answers to pertinent questions Contact number for questions/injuries14%62% Statement that participation is voluntaryParticipation is voluntary81%49% Statement that refusal to participate will involve no penalty or loss of benefits/ Statement that the subject may discontinue participation at any time without penalty Ability to withdraw and not continue with the donation process 29%11% Common essential elements

23 Transfusion Jun;49(6):

24 Transfusion Jun;49(6): Specific blood donation elements ElementDetailICF (n=21) PCF (n=37) Description of the procedurePre/post donation process14%51% Pre-screening/eligibility10%38% Estimated time for donation0%24% Infection disease testingGeneral statement about ID testing95%62% Statement that blood will be tested for HIV/AIDS 81%68% Statement that blood will be tested for Hepatitis B and C 62%46% Discovery of a positive ID test reported to donor and/or parent 71%73% Explanation of whom to contact in the event of an injury Contact number in case of injury10%5% Anticipated circumstances under which participation may be terminated Causes of deferral (Permanent or temporary) 62%24% Any additional costs to that may resultAdverse events or positive ID test may result in additional expenses and physician examinations for outside treatment. 10%8% Written consent form approved by the IRB and signed and dated by subject or subject's legally authorized representative Signature on the consent form100%

25 Transfusion Jun;49(6):

26 Transfusion Jun;49(6): Unique minor age elements ElementPCF (n=37) Length of period consent is valid100% Parent contact number documented on the consent form 54% Acknowledgement on the form consenting for medical treatment in case of an emergency by parent 3%

27 Study limitations A number of limitations include that: 1) the investigators were not blinded to the blood center name when evaluating ICFs and PCFs; 2) the scoring system used was subjective and not previously employed in others studies or validated; 3) the investigators could not evaluate the entire informed consent process; 4) some of the informed consents were downloaded from the internet and therefore may not be accurate or the most current version used at the blood center; and 5) the use of the research informed consent essential elements as the model for the essential elements for whole blood donation. Some of the elements of the research consent may not directly applicable to whole blood donation. These elements include the individual will not have direct benefit (which at times is true in the research setting), and there are not alternatives to whole blood donation (with the possible exception of blood component collection by apheresis). Nonetheless, the investigators believe that the data are important and timely, and that key conclusions can be drawn and recommendations made.

28 Study recommendations Most parental consent forms and informed consent forms with the related general information forms do not contain the majority of the common essential or specific blood donation elements Recommend an intervention to remedy this, such as nation-wide task force to make recommendations